|
Books > Medicine > Clinical & internal medicine > Hepatology
Dr. Rustgi has assembled the leading experts in the management of
Heptatitis B to present the current treatment and clinical course
for diagnosis and management of the disease. Articles are devoted
to: Drug metabolism in the liver; Mechanism of Liver Damage
including the RUCAM scale; Drug-induced acute liver failure;
Epidemiology and genetic risk factors; Adverse drug reactions: type
A (intrinsic or pharmacological) or type B (idiosyncratic);
Pathology of injury including phenotypes; The clinical course of
drug-induced liver disease; Environmental factors of drug
hepatotoxicity; Newer agents in drug hepatotoxicity; Drug
hepatotoxicity: herbal products; Drug hepatotoxicity: models
including "human on a chip" and zebrafish; Acute and chronic liver
failure from drugs: impact on the kidney; and Management of acute
hepatotoxicity including medical agents and liver support systems.
Readers will come away with the cutting edge science behind the
latest innovations in the treatment of Hepatitis B.
Dr. Levy has secured the field's top experts to offer the latest
clinical reviews on cholestatic liver disease. The issue will
include articles devoted to The Gut-Liver Axis; Update on Genetics
in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis;
New thoughts on IgG4 Associated Cholangitis; Cancer Risk and
Surveillance in PSC; Novel Therapies for PBC; and Liver
transplantation for Cholestatic Liver Diseases, to name a few. Dr.
Levy's issue will be the most current authority on cholestatic
liver disease.
![Medical Medium Liver Rescue - Answers To Eczema, Psoriasis, Diabetes, Strep, Acne, Gout, Bloating, Gallstones, Adrenal Stress,...](//media.loot.co.za/images/x80/344744071233179215.jpg) |
Medical Medium Liver Rescue
- Answers To Eczema, Psoriasis, Diabetes, Strep, Acne, Gout, Bloating, Gallstones, Adrenal Stress, Fatigue, Fatty Liver, Weight Issues, SIBO & Autoimmune Disease
(Hardcover)
Anthony William
3
|
R765
R597
Discovery Miles 5 970
Save R168 (22%)
|
In Stock
|
|
The #1 New York Times best-selling author and beloved healing authority reveals how taking your liver off overload can help resolve a wide range of symptoms and conditions--and transform your health in ways you've never imagined.
What if you could focus on one aspect of your well-being to transform all the others--and at the same time prevent health problems you didn't even know were lurking beneath the surface?
In today's world, we have no idea how many symptoms, conditions, and diseases are rooted in an overloaded liver. It's not only about liver cancer, cirrhosis, and hepatitis. Nearly every challenge--from pesky general health complaints to digestive issues to emotional struggles to weight gain to high blood pressure to heart problems to brain fog to skin conditions to autoimmune and other chronic illnesses--has an origin in an overloaded liver and can improve and heal when you harness the force of this humble organ.
Medical Medium Liver Rescue offers the answers you should have had all along. With his signature compassion, Anthony William, the Medical Medium, shares unparalleled insights into undiscovered functions of our life-saving livers, explains what's behind dozens of health issues that hold us back, and offers detailed guidance on how to move forward so we can live our best lives. Find out for yourself what liver rescue is all about: being clearer-headed, more peaceful, happier, and better able to adapt to our fast-changing times. Learn how to sleep well, balance blood sugar, lower blood pressure, lose weight, and look and feel younger. A healthy liver is the ultimate de-stressor, anti-aging ally, and safeguard against a threatening world--if we give it the right support.
![Hepatotoxicity (Hardcover): Costin Teodor Streba, Ion Rogoveanu, Cristin Constantin Vere](//media.loot.co.za/images/x80/4598124777548179215.jpg) |
Hepatotoxicity
(Hardcover)
Costin Teodor Streba, Ion Rogoveanu, Cristin Constantin Vere
|
R2,837
Discovery Miles 28 370
|
Ships in 10 - 15 working days
|
|
Drug-Induced Liver Injury, Volume 85, the newest volume in the
Advances in Pharmacology series, presents a variety of chapters
from the best authors in the field. Chapters in this new release
include Cell death mechanisms in DILI, Mitochondria in DILI,
Primary hepatocytes and their cultures for the testing of
drug-induced liver injury, MetaHeps an alternate approach to
identify IDILI, Autophagy and DILI, Biomarkers and DILI,
Regeneration and DILI, Drug-induced liver injury in obesity and
nonalcoholic fatty liver disease, Mechanisms of Idiosyncratic
Drug-Induced Liver Injury, the Evaluation and Treatment of
Acetaminophen Toxicity, and much more.
In this issue of Clinics in Liver Disease, guest editor Dr. John V.
Binu brings his considerable expertise to the topic of Primary
Biliary Cholangitis. PBC leads to inflammation and scarring of the
small bile ducts, and, if untreated, can lead to cirrhosis and
liver failure. In this issue, top experts provide a
state-of-the-art review of diagnosis and treatment for this
chronic, progressive liver disorder. Contains 13 practice-oriented
topics including genetics of primary biliary cholangitis;
prognostic scoring systems in PBC; overlap syndromes and PBC;
non-invasive evaluation of fibrosis and portal hypertension in PBC;
treatment of PBC: first- and second-line therapies; novel therapies
for PBC; and more. Provides in-depth clinical reviews on primary
biliary cholangitis, offering actionable insights for clinical
practice. Presents the latest information on this timely, focused
topic under the leadership of experienced editors in the field.
Authors synthesize and distill the latest research and practice
guidelines to create clinically significant, topic-based reviews.
In this issue of Radiologic Clinics, guest editors Drs. Benjamin M.
Yeh and Frank H. Miller bring their considerable expertise to the
topic of Hepatobiliary Imaging. Top experts in the field offer
comprehensive reviews of every major aspect of hepatobiliary
imaging: biliary cancer, trauma, vascular disorders, and benign
liver disease. This issue also includes articles on imaging
modalities (MR, CT, ultrasound), contrast agents, and "Pearls and
Pitfalls." Contains 13 practice-oriented topics including
abbreviated MR liver protocols; update on MR contrast agents for
liver imaging: what to use and when; biliary imaging interpretation
pearls and pitfalls: CT and MRI; update on biliary cancer imaging;
atypical liver malignancies and diagnostic pitfalls; and more.
Provides in-depth clinical reviews on hepatobiliary imaging,
offering actionable insights for clinical practice. Presents the
latest information on this timely, focused topic under the
leadership of experienced editors in the field. Authors synthesize
and distill the latest research and practice guidelines to create
clinically significant, topic-based reviews.
Liver Pathophysiology: Therapies and Antioxidants is a complete
volume on morphology, physiology, biochemistry, molecular biology
and treatment of liver diseases. It uses an integral approach
towards the role of free radicals in the pathogenesis of hepatic
injury, and how their deleterious effects may be abrogated by the
use of antioxidants. Written by the most prominent authors in the
field, this book will be of use to basic and clinical scientists
and clinicians working in the biological sciences, especially those
dedicated to the study and treatment of liver pathologies.
In this issue of Clinics in Liver Disease, guest editor Mitchell L
Shiffman brings considerable expertise to the topic of Challenging
Issues in the Management of Chronic Hepatitis B Virus. Provides
in-depth, clinical reviews on the latest updates in Challenging
Issues in the Management of Chronic Hepatitis B Virus, providing
actionable insights for clinical practice. Presents the latest
information on this timely, focused topic under the leadership of
experienced editors in the field; Authors synthesize and distill
the latest research and practice guidelines to create these timely
topic-based reviews.
In this issue of Clinics in Liver Disease, Guest Editor Paul Kwo
brings his considerable expertise to the topic of Alcoholic
Hepatitis. Top experts in the field cover key topics such as the
Epidemiology of Alcoholic Hepatitis, Nutrition in Those with
Alcoholic Hepatitis, Current therapies for alcoholic hepatitis,
Selection Criteria for Liver Transplantation for Acute Alcoholic
Hepatitis, and more. Provides in-depth, clinical reviews on
Alcoholic Hepatitis, providing actionable insights for clinical
practice. Presents the latest information on this timely, focused
topic under the leadership of experienced editors in the field;
Authors synthesize and distill the latest research and practice
guidelines to create these timely topic-based reviews. Contains 11
relevant, practice-oriented topics including Emerging Therapies for
alcoholic hepatitis; Diagnosis of Alcoholic Hepatitis; Moderate
Alcoholic Hepatitis; Current and Future Biomarkers in Alcoholic
Hepatitis, and more.
With collaboration from Consulting Editor, Dr. Norman Gitlin Dr.
Goldberg has assembled a state-of-the-art issue devoted to
management of liver transplant patients. Expert authors have
contributed current clinical reviews that covers the breadth of the
pre- and post-surgical journey. Articles are specifically devoted
to the following topics: Obesity management of liver transplant
waitlist candidates and recipients; Expanding the limits of liver
transplantation for hepatocellular carcinoma: Is there a limit;
Frailty and sarcopenia in patients pre- and post-liver transplant;
Achieving tolerance in liver transplantation: Where are we now and
what does the future hold; Expanding role of donation after cardiac
death donors; Optimizing selection of patients for simultaneous
liver-kidney transplant; Keeping the patient with end-stage liver
disease alive while awaiting transplant: Management of
complications of portal hypertension; Expanding donor selection and
recipient indications for living donor liver transplantation; The
changing liver transplant recipient: From hepatitis C to NASH and
alcohol; Cardiovascular risk stratification in liver transplant
candidates; The role of machine perfusion in liver transplantation:
Warm, Cold, or does it not matter; Paradigm shift in utilization of
livers from hepatitis C-viremic donors into HCV-negative patients;
Transplantation of elderly patients: Is there an upper age cutoff;
Transplantation for acute alcoholic hepatitis: Controversies and
early successes. Hepatologists will come away with the information
they need to improve outcomes in liver transplant patients.
|
|